Biopharma Business

Tag "Naptar"

Orphan Drug Natpar Receives EMA Recommendation

The European Medicines Agency (EMA) announced on Feb. 24, 2017 that its Committee for Medicinal Products for Human Use (CHMP) has granted conditional marketing authorization in the European Union to Natpar

Read Full Article

Upcoming Events


The Magazine

New Subscriber

Subscribe Here